Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Dermatologists are crucial in providing personalized care for patients with sex development differences.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Traditional Chinese Medicine, combined with antiandrogen therapy, could improve treatment and reduce side effects for genetic hair loss.

Sex hormone therapy is effective for certain skin conditions like acne and seborrhea, but less so for female hair loss and excessive hair growth.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

Stem cell therapies show promise for hair regrowth in androgenetic alopecia.

Stem cell treatments show promise for hair loss but need more research.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Low testosterone can cause a heart rhythm problem in men, but fixing it can prevent the issue.

Hair growth and health are influenced by factors like age, environment, and nutrition, and are controlled by various molecular pathways. Red light can promote hair growth, and understanding these processes can help treat hair-related diseases.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Interest in new and personalized treatments for hair loss is growing.

Estrogen may help improve COVID-19 outcomes, especially in women.

Patients with Complete Androgen Insensitivity Syndrome need psychological support and multidisciplinary care for complex treatment decisions.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

The study found that imaging might miss small ovarian tumors causing high testosterone, and suggested using certain testosterone levels and treatment responses to identify these tumors.

Men's fertility and sexual health decline with age, with reduced testosterone and virility, and many lose fertility by their eighties.

New hair follicles could be created to treat hair loss.

New regenerative therapies show promise for treating hair loss.

New treatments for hair loss could involve using stem cells and a process called the Wnt/beta-catenin pathway to stimulate hair growth.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Increased FGFR2b signaling, influenced by androgens, plays a role in causing acne.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.